Randy Teel
President & Chief Executive Officer Arvinas, Inc.
Seminars
Tuesday 27th October 2026
Degradation Delivered – What the First TPD Approval Means for the Future of the Field
8:30 am
- Significance of the first approved targeted protein degrader
- What the future of TPD holds beyond oncology; other targets to explore and consider
- High-level overview of what is next for Arvinas, it’s pipeline and targets
